Clinical trial Recruiting at 1 site Observational Ages 18 and up

Collagen matrix or palatal graft versus natural healing for preserving the front-tooth ridge

Official title: Alveolar Ridge Preservation With a Xenograft (Bio-Oss® Collagen) and a Collagen Matrix (Mucograft® Seal) or a Free Connective Tissue Graft Versus Spontaneous Healing:A 5-year Follow up

Run by Erasmus Medical Center · NCT05663385 · Data updated 2026-11-12

This follow-up will see if using a collagen matrix or a palatal connective tissue graft with a bone xenograft helps preserve gum and bone around a single front-tooth implant better than letting the socket heal on its own in people who had early implant placement.

More Dental Implant trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment75 (estimated)
SponsorErasmus Medical Center
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Rotterdam)
StatusRecruiting
StartedApril 16, 2024
Main results expectedAugust 14, 2025
Study endsOctober 1, 2025
Registry record updatedAugust 12, 2025
Trial IDNCT05663385 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults who participated in the original randomized trial of ARP versus spontaneous healing and who did not receive head-and-neck radiotherapy or current chemotherapy and can maintain basic oral hygiene.

Probably not a fit

People who had different implant procedures (e.g., posterior or multiple-tooth replacements), received radiotherapy/chemotherapy during follow-up, or cannot perform basic oral hygiene are unlikely to benefit from this follow-up.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective 5-year observational follow-up of patients previously enrolled in a randomized comparison of alveolar ridge preservation (ARP) techniques versus spontaneous healing prior to early implant placement in the anterior maxilla. Participants received either a xenograft plus a collagen matrix or a xenograft plus a free palatal connective tissue graft, or were managed with spontaneous healing, and will be re-examined up to five years after functional loading. The primary outcome is the midfacial mucosal (buccal marginal gingiva) level, with secondary outcomes including PES/WES esthetic scores, complications, implant survival and success, plaque index, and modified bleeding index. No new interventions are planned; the study documents long-term clinical, esthetic, and patient-reported outcomes at Erasmus Medical Center.

Why it matters

Potential benefit: If successful, the results could show which socket management approach best preserves gum and bone long-term and so improve esthetic outcomes and implant stability for front-tooth replacements.

How similar studies have gone: Prior work (including the original RCT and reports of socket-seal techniques) showed good short-term esthetic outcomes and similar results up to one year, but long-term (5-year) comparative data are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients previously included in the above mentioned RCT.

Exclusion Criteria:

* Patients treated with radiotherapy during follow-up in the head-and-neck region or current chemotherapy; disability (mental and/or physical) to maintain basic oral hygiene procedures.

Where it's running

  • Erasmus Mc
    Rotterdam, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.